| Immune landscape after allo-HSCT: TIGIT-and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse V Gournay, N Vallet, V Peux, K Vera, J Bordenave, M Lambert, A Corneau, ... Blood, The Journal of the American Society of Hematology 140 (11), 1305-1321, 2022 | 44* | 2022 |
| n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation F Picou, C Debeissat, J Bourgeais, N Gallay, E Ferrié, A Foucault, ... Pharmacological research 136, 45-55, 2018 | 37 | 2018 |
| Occupational pesticide exposure increases risk of acute myeloid leukemia: a meta-analysis of case–control studies including 3,955 cases and 9,948 controls A Foucault, N Vallet, N Ravalet, F Picou, MC Bene, E Gyan, O Herault Scientific reports 11 (1), 2007, 2021 | 30 | 2021 |
| Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study A Jourdes, E Cellerin, C Touzeau, S Harel, B Denis, G Escure, E Faure, ... Clinical Microbiology and Infection 30 (6), 764-771, 2024 | 24* | 2024 |
| A novel inhibitor of STAT5 signaling overcomes chemotherapy resistance in myeloid leukemia cells M Brachet-Botineau, M Deynoux, N Vallet, M Polomski, L Juen, O Hérault, ... Cancers 11 (12), 2043, 2019 | 24 | 2019 |
| Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM … N Vallet, FS de Fontbrune, M Loschi, D Desmier, A Villate, F Barraco, ... Haematologica 103 (3), e103, 2018 | 24 | 2018 |
| Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation N Vallet, S Le Grand, L Bondeelle, B Hoareau, A Corneau, D Bouteiller, ... Blood, The Journal of the American Society of Hematology 140 (23), 2500-2513, 2022 | 23 | 2022 |
| Automated early detection of myelodysplastic syndrome within the general population using the research parameters of beckman–coulter DxH 800 hematology analyzer N Ravalet, A Foucault, F Picou, M Gombert, E Renoult, J Lejeune, N Vallet, ... Cancers 13 (3), 389, 2021 | 18 | 2021 |
| Can some anticancer treatments preserve the ovarian reserve? N Vallet, N Boissel, E Elefant, F Chevillon, H Pasquer, C Calvo, N Dhedin, ... The Oncologist 26 (6), 492-503, 2021 | 17 | 2021 |
| The role of erythroferrone in iron metabolism: From experimental results to pathogenesis N Vallet La Revue de Medecine Interne 39 (3), 178-184, 2017 | 14* | 2017 |
| Toward practical transparent verifiable and long-term reproducible research using Guix N Vallet, D Michonneau, S Tournier Scientific Data 9 (1), 597, 2022 | 13 | 2022 |
| No survival improvement in patients with high‐risk multiple myeloma harbouring del (17p) and/or t (4; 14) over the two past decades. T Chalopin, N Vallet, O Theisen, M Ochmann, M Tiab, P Godmer, C Barin, ... British Journal of Haematology 194 (3), 2021 | 13 | 2021 |
| Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported cases N Vallet, M Ertault, JB Delaye, T Chalopin, A Villate, L Drieu La Rochelle, ... Annals of Hematology 99, 229-239, 2020 | 12 | 2020 |
| Specific changes of erythroid regulators and hepcidin in patients infected by SARS-COV-2 JB Delaye, H Alarcan, N Vallet, C Veyrat-Durebex, L Bernard, O Hérault, ... Journal of Investigative Medicine 70 (4), 934-938, 2022 | 11 | 2022 |
| Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures L Dubouchet, H Todorov, R Seurinck, N Vallet, S Van Gassen, A Corneau, ... Science Translational Medicine 14 (633), eabg3083, 2022 | 10 | 2022 |
| Low-dose pesticides alter primary human bone marrow mesenchymal stem/stromal cells through ALDH2 inhibition A Foucault, N Ravalet, J Besombes, F Picou, N Gallay, L Babin, ... Cancers 13 (22), 5699, 2021 | 10 | 2021 |
| Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses N Vallet, M Salmona, J Malet-Villemagne, M Bredel, L Bondeelle, ... Cell Host & Microbe 31 (8), 1386-1403. e6, 2023 | 9 | 2023 |
| Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report T Chalopin, N Vallet, M Morel, R Maguet, L d’Alteroche, G de Pinieux, ... Journal of Medical Case Reports 15, 1-5, 2021 | 7 | 2021 |
| Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with KMT2Ar or NPM1 Alterations C Recher, J O'Nions, I Aldoss, AA Pierola, A Allred, ... Blood 144, 215, 2024 | 5 | 2024 |
| Retrospective review of end-of-life care in the last month of life in older patients with multiple myeloma: what collaboration between haematologists and palliative care teams? T Chalopin, N Vallet, L Benboubker, M Ochmann, E Gyan, F Chaumier BMJ Supportive & Palliative Care 14 (e1), e380-e383, 2020 | 5 | 2020 |
Emmanuel GyanProfesseur des des Universités, Praticien Hospitalier, Faculté de Médecine, Université de ToursPotvrđena adresa e-pošte na univ-tours.fr
